| Product | Code | ||
|---|---|---|---|
| SCYL1 Antibody (N-term) | AP7215a | 400 µl |
Contact us |
| SCYL1 Antibody | AP7215d | 400 µl |
Contact us |
| PRAK (MAPKAPK5) Antibody (T182) | AP7216a | 400 µl |
Contact us |
| DAPK2 Antibody (N-term) | AP7218A | 400 µl |
Contact us |
| DRAK1 Antibody (N-term) | AP7220a | 400 µl |
Contact us |
| MAPK12 Antibody (Center) | AP7224C | 400 µl |
Contact us |
| MAPK13 Antibody (C-term) | AP7225c | 400 µl |
Contact us |
| MAPK14 Antibody (Center) | AP7226c | 400 µl |
Contact us |
| MAPK14 Antibody (T180/Y182) | AP7226f | 400 µl |
Contact us |
| MAPK8 Antibody (Center) | AP7227c | 400 µl |
Contact us |
| JNK2 (MAPK9) Antibody (Center) | AP7228c | 400 µl |
Contact us |
| MAPKAPK2 Antibody (C-term) | AP7229b | 400 µl |
Contact us |
Abcepta
Abcepta is a leading manufacturer of primary antibodies with more than fifteen years of experience. We supply quality antibodies and related products drug discovery and academic laboratories worldwide. Our focus is on targets covering the major research areas impacting health and disease, including cancer, metabolism, cardiovascular, neuroscience, and stem cells.
More information?Contact Us by e-mail info@divbio.eu